Bayer abandons clinical trials of new anti-stroke treatment
641075
German pharmaceuticals giant Bayer said it had decided to pull out of clinical testing of Repinotan, a compound used to treat stroke patients, because the drug had not lived up to expectations.
635918
No. 1 drugmaker to end marketing push after study points to higher risk of heart attack, stroke. NEW YORK (CNN) - Under pressure from regulators, Pfizer has agreed to limit advertising of Celebrex after a
468296
Doctors in the United States have shunned GlaxoSmithKline Plc's diabetes drug Avandia since a study was published last week linking the drug to heart-attack risk, according to daily prescription data.
303738
Drug and medical device makers will not be forced to disclose the results of clinical trials on some products that never reached the marketplace.
142196
The abrupt decision to discontinue the drug was a shocking disappointment for Pfizer and for people who suffer from heart disease.
564001
A drug being developed by Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some liver cancer patients and temporarily stabilized the
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
745620
Pressured by regulators, Bayer AG said it will withdraw the controversial heart surgery drug Trasylol after a Canadian study suggested that it increased death rates.
667642
In a surprising setback for the  world's largest drugmaker, Pfizer Inc.  halted  development on Saturday of its top experimental medicine, the  cholesterol drug torcetrapib, due to safety concerns.
37828
A clinical trial of the blockbuster arthritis drug Celebrex was shut down yesterday after researchers found an increase in the risk of serious heart disease and strokes in those taking the
418057
Johnson & Johnson's daffodil-extract Alzheimer's treatment yanked from market.
206852
The federal government yesterday canceled a $100 million study designed to test a new generation of drugs to prevent breast cancer in women at risk for the disease.
683010
NEW YORK, Dec. 2 -- Pfizer Inc. announced Saturday that it has cut off all clinical trials and development work for a cholesterol drug that was supposed to be a star product because of an unexpected number of deaths and cardiovascular problems among patients who used it.
431712
Drug company Pfizer has pulled its advertising of arthritis drug Celebrex following a study suggesting it could cause heart attacks and strokes.
465328
NEW YORK -- Pfizer Inc. said yesterday it has halted all clinical trials and development for a cholesterol drug because of an unexpected number of deaths and cardiovascular problems in patients who used it.
655214
In "surprising and disappointing" news, its promising new drug fails clinical trials.
637892
Boston Scientific receives a warning letter from the FDA on a discontinued stent trial.